Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bousquet

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|December 19, 2014
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndromeVincent Gasparik, Hugues Greney, Stephan Schann, et al.
Autonomic Neuroscience : Basic & Clinical|February 2, 2019
I<sub>1</sub>-imidazoline receptor-mediated cardiovascular and metabolic effects in high-fat diet-induced metabolic syndrome in ratsAlessandro R Nascimento, Fabiana Gomes, Marcus V Machado, et al.
Optics Express|September 22, 2011
Polarization state studies in second harmonic generation signals to trace atherosclerosis lesionsCamille Doras, Gregory Taupier, Alberto Barsella, et al.
Molecular Pharmacology|June 18, 2002
[125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptorsHugues Greney, Dragan Urosevic, Stephan Schann, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 28, 2015
Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intoleranceMaud Weiss, Soumaya Bouchoucha, Farouk Aiad, et al.
Plos One|March 9, 2010
Cardiac muscarinic receptor overexpression in sudden infant death syndromeAngelo Livolsi, Nathalie Niederhoffer, Nassim Dali-Youcef, et al.
Journal of Hypertension|April 7, 2007
The sympathetic nervous system and the metabolic syndromeGiuseppe Mancia, Pascal Bousquet, Jean Luc Elghozi, et al.
Circulation|March 6, 2002
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulationVéronique Bruban, Vanessa Estato, Stephan Schann, et al.
Circulation|October 31, 2002
First model of spontaneous vagal hyperreactivity and its mode of genetic transmissionAngelo Livolsi, Josiane Feldman, Josué Feingold, et al.
Journal of Medicinal Chemistry|May 16, 2003
Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analoguesFrancesco Gentili, Pascal Bousquet, Livio Brasili, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 19, 2014
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndromeVincent Gasparik, Hugues Greney, Stephan Schann, et al.
Autonomic Neuroscience : Basic & Clinical|February 2, 2019
I<sub>1</sub>-imidazoline receptor-mediated cardiovascular and metabolic effects in high-fat diet-induced metabolic syndrome in ratsAlessandro R Nascimento, Fabiana Gomes, Marcus V Machado, et al.
Optics Express|September 22, 2011
Polarization state studies in second harmonic generation signals to trace atherosclerosis lesionsCamille Doras, Gregory Taupier, Alberto Barsella, et al.
Molecular Pharmacology|June 18, 2002
[125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptorsHugues Greney, Dragan Urosevic, Stephan Schann, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 28, 2015
Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intoleranceMaud Weiss, Soumaya Bouchoucha, Farouk Aiad, et al.
Plos One|March 9, 2010
Cardiac muscarinic receptor overexpression in sudden infant death syndromeAngelo Livolsi, Nathalie Niederhoffer, Nassim Dali-Youcef, et al.
Journal of Hypertension|April 7, 2007
The sympathetic nervous system and the metabolic syndromeGiuseppe Mancia, Pascal Bousquet, Jean Luc Elghozi, et al.
Circulation|March 6, 2002
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulationVéronique Bruban, Vanessa Estato, Stephan Schann, et al.
Circulation|October 31, 2002
First model of spontaneous vagal hyperreactivity and its mode of genetic transmissionAngelo Livolsi, Josiane Feldman, Josué Feingold, et al.
Journal of Medicinal Chemistry|May 16, 2003
Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analoguesFrancesco Gentili, Pascal Bousquet, Livio Brasili, et al.
Pageof 5